Urinary metabolic profile of 19-norsteroids in humans: Glucuronide and sulphate conjugates after oral administration of 19-nor-4-androstenediol

Susana Torrado, Meritxell Roig, Magi Farré, Jordi Segura, Rosa Ventura

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)

Abstract

19-Nor-4-androstenediol (NOL) is a prohormone of nandrolone (ND). Both substances are included in the WADA List of Prohibited Classes of Substances and their administration is determined by the presence of 19-norandrosterone (NA) with the urinary threshold concentration of 2 ng mL-1. Routine analytical procedures allow the determination of NA excreted free and conjugated with glucuronic acid, but amounts of ND and NOL metabolites are also excreted in the sulphate fraction. The aim of this study is to determine the urinary metabolic profile after oral administration of a nutritional supplement containing NOL. Urine samples were collected up to 96 h following supplement administration and were extracted to obtain separately three metabolic fractions: free, glucuronide and sulphate. Extraction with tert-butyl methyl ether was performed after the hydrolysis steps and trimethylsilyl derivatives were analyzed by gas chromatography/mass spectrometry (GC/MS). After oral administration of NOL, the main metabolites detected were NA and noretiocholanolone (NE) in the glucuronide and sulphate fractions. The relative abundances of each metabolite in each fraction fluctuate with time; a few hours after administration the main metabolite was NA glucuronide whereas in the last sample (4 days after administration) the main metabolite was theNAsulphate and the second was the NE glucuronide. During the studied period almost half of the dose was excreted and the main metabolites were still found in urine after 96 h. Norepiandrosterone and norepietiocholanolone were also detected only in the sulphate fraction. Our results suggest that sulphate metabolites should be taken into consideration in order to increase the retrospectivity in the detection of 19-norsteroids after oral administration. Copyright © 2008 John Wiley & Sons, Ltd.
Original languageEnglish
Pages (from-to)3035-3042
JournalRapid Communications in Mass Spectrometry
Volume22
DOIs
Publication statusPublished - 15 Oct 2008

Fingerprint

Dive into the research topics of 'Urinary metabolic profile of 19-norsteroids in humans: Glucuronide and sulphate conjugates after oral administration of 19-nor-4-androstenediol'. Together they form a unique fingerprint.

Cite this